Literature DB >> 24913390

When can we cure Crohn's?

Gerassimos J Mantzaris1.   

Abstract

Crohn's disease is a life-long idiopathic inflammatory disease which affects the entire gastrointestinal tract and occasionally extra-intestinal organs. CD is thought to result from complex interactions between environmental factors, the gut microbes, and the genetic background and the immune system of the host. In the last decades research on these pathogenetic components, and especially on mucosal immunity, has led to the development of biologic agents and therapeutic strategies that have improved dramatically the treatment of CD but we are still far away from curing the disease. If there is a treatment for CD that will probably evolve through methodical steps towards integrating research on all the components involved in the pathogenesis of CD. This holistic and global approach may aid at unravelling the mysteries of CD and developing novel agents and therapeutic strategies which by targeting multiple pathogenetic pathways and at different stages of disease may lead hopefully to cure.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aminosalicylates; Biologics; Corticosteroids; Crohn's disease; Environmental factors; Feacal microbiota transplantation; Genetics; Gut microbiota; Immunosuppressants; Mucosal immunity

Mesh:

Substances:

Year:  2014        PMID: 24913390     DOI: 10.1016/j.bpg.2014.04.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  3 in total

1.  The relationship between neutrophil/lymphocyte and platelet/lymphocyte ratios with oxidative stress in active Crohn's disease patients.

Authors:  F C Eraldemir; M Musul; A E Duman; B Oztas; C Baydemir; S Hulagu
Journal:  Hippokratia       Date:  2016 Oct-Dec       Impact factor: 0.471

2.  Human Embryonic Stem Cell Therapy in Crohn's Disease: A Case Report.

Authors:  Geeta Shroff
Journal:  Am J Case Rep       Date:  2016-02-29

Review 3.  Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets.

Authors:  Teodora-Ecaterina M Manuc; Mircea M Manuc; Mircea M Diculescu
Journal:  Clin Exp Gastroenterol       Date:  2016-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.